All india institute of medical sciences bhopal, Educational entrance examination

All India Institute of Medical Sciences Bhopal has begun the clinical trial of the drug Mycobacterium (Mw) on a COVID-19 patient on Thursday."(For the) first time globally, the first dose of the trial drug Mycobacterium (Mw) was administered to a COVID-19 patient today (Thursday) under the supervision of a clinical trial team of doctors under the leadership of Dr Sarman Singh, Director, AIIMS, Bhopal," said a release from the hospital.Dr Sarman Singh, the Director hospital, said, "the hospital was the first to receive the medicine and first to start the clinical trial by administering the drug to a patient.""The patients are distributed in three groups and in the initial phase the drug is administered to the critical patients in ICU," he added.( With inputs from ANI )

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Narendra Modi

Lok Sabha Election 2024

Heatwave In India

Mumbai Water Cut

Maharashtra Lok Sabha Election

IPL 2024

All India Institute Of Medical Sciences BhopalFOLLOW

All india institute of medical sciences bhopal, Latest News

Health :400 medicinal plants have anti-diabetic properties: Researchers

New Delhi, May 27 At least 400 medicinal plants have anti-diabetic properties that can control Type 2 diabetes, ... ...

National :AIIMS Bhopal begins clinical trial of Mycobacterium (Mw) on COVID-19 patient

All India Institute of Medical Sciences Bhopal has begun the clinical trial of the drug Mycobacterium (Mw) on a COVID-19 patient on Thursday. ...